NSETrading Window2d ago · 23 Sept 2026, 06:10 pm
Trading Window
Aarey Drugs & Pharmaceuticals Limited · AAREYDRUGS
✦ AI Summary
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. Worth Investment & Trading Co Limited has also informed the Exchange regarding the Trading Window closure for its insiders.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
AAREYDRUGS_23092026181036_Worth_Closure_of_trading_window_September_2026.pdf
View document text
WORTH INVESTMENT & TRADING CO LIMITED
CIN: L67120MH1980PLC343455
497/501, Village Biloshi, Taluka Wada, Thane MH- 421303
Tel:-022-62872900 Email:worthinvestmenttrading@gmail.com Site: www.worthinv.com
Date:- 23rd September, 2026
The Corporate Services Dept.
BSE Limited.
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai - 400001.
Scrip Code: 538451
Subject: Closure of trading window
Dear Sir/Ma’am,
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 (including any statutory
modification(s) or re-enactment(s) thereof, for the time being in force) and with reference to Circulars
issued by BSE vide Circular No. LIST/COMP/01/2019-20, we wish to inform you that the trading window
for dealing in the securities/shares of Worth Investment and Trading Co Limited will remain closed for
Insiders, Designated Persons and their immediate relatives with effect from Thursday, October 01, 2026,
till the completion of 48 hours after the declaration of the Unaudited Financial Results of the Company
for the quarter and half year ended September 30, 2026.
The Company has intimated its Designated Persons regarding the closure of the trading window.
Accordingly, Insiders, Designated Persons and their immediate relatives of the Company are advised not
to trade (buy or sell or pledge, etc.) in the securities/shares of the Company during the aforesaid period
of closure of the trading window.
Board Meeting date for consideration and approval of Unaudited Financial Results of the Company for
the quarter and half year ended September 30, 2026, shall be intimated in due course.
Kindly take the above information on your records.
Thanking you,
Yours faithfully,
For Worth Investment & Trading Co Limited
Nimit Ghatalia
Director
DIN: 07069841